Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma

Keyphrases

• Clinical Development 100%
• Glioblastoma 100%
• Immune Checkpoint Inhibitors 100%
• Checkpoint Inhibitors 57%
• Tumor 28%
• Successful Implementation 28%
• Solid Cancer 28%
• Standard of Care 14%
• Median Overall Survival 14%
• Effector Function 14%
• Intracranial Tumor 14%
• T Cell Infiltration 14%
• Multiple Steps 14%
• Expert Opinion 14%
• Inflammatory Response 14%
• Multimodality Approach 14%
• Area Cover 14%
• Cytotoxic T Cells 14%
• Repeated Sampling 14%
• Tumor-specific Immune Response 14%
• Combinatorial Approach 14%
• Tumor mutation Burden 14%
• Immunosuppressive Mechanisms 14%
• Immunotherapy Approaches 14%

Immunology and Microbiology

• Immunotherapy 100%
• Immune Checkpoint Inhibitor 100%
• T Cell 50%
• Immune Response 50%
• Overall Survival 50%
• Immunosuppressive Drug 50%
• Cytotoxic T Cell 50%
• Cell Infiltration 50%
• Inflammation Response 50%